સરકારી યોજના , સરકારી ભરતી અને લેટેસ્ટ ન્યૂઝ માટે અમારા વોટ્સઅપ નંબર 6359046271 ને તમારા વોટ્સએપ ગ્રુપ માં એડ કરો

Search This Website

Monday, 23 November 2020

Corona Vaccine Update

Corona Vaccine Update: Modern vaccines will cost from Rs 1850 to Rs 2750, with final decision pending; After Serum, now the CEO of Modern also announced the price of the vaccine

Modern vaccine is expensive, Russia said, we will give cheap vaccine

Vaccine prices are also being announced by various companies among the growing number of corona patients. Stephen Bensell, CEO of the American company Moderna, which claims to have developed the Corona vaccine, said that a single dose of the modern Corona vaccine would cost between 25 25 and (37 (approximately Rs. 1850 to 2750). According to some reports, a single dose of Pfizer can cost up to 19 19.5 (approximately Rs. 1450). Earlier, Adar Poonawala, CEO of Serum Institute, had also given information about the possible cost of the corona vaccine.

The government has completed a third phase trial.
On the other hand, Russia has said that the cost of a single dose of our vaccine Sputnik-5 will be much lower than that of large companies such as Moderna and Pfizer. 


The vaccine is being developed by Russia's Gameplay Research Center. He registered Sputnik-5 as the world's first vaccine on August 11. With the completion of the third phase of the trial, the central government has begun examining the companies' approvals for the use of the vaccine and its feasibility. With this, the process of its license has also started.



Emergency use approved in Britain The
the central government recently met on the issue of pre-purchase, including pricing of vaccines. Vinod Paul, a member of the Police Commission (Health), and K.S. Vijayaraghavan and Health Secretary Rajesh Bhushan were also present. It was decided that the Prime Minister's Office would form a committee to decide on the cost of the vaccine and other decisions. 


The third phase of the co-vaccine trial of Serum, Bharat Biotech and ICMR is currently underway in the country. According to sources, the AstraZeneca vaccine has been approved for emergency use in Britain, so it could happen in India as well.

AstraZeneca will test for antibody treatment, a corona discharge does not occur until the year
will be a trial associated with London - AstraZeneca for the treatment of Britain koronani antibody. According to the company, its new 'antibody cocktail' will not allow corona infection for a year. 


The test will start from Manchester. 5000 partners will be recruited in this new trial. The purpose of this test is to gather information about the proteins made in our body, which act like natural antibodies in the immune system.





Company and potential cost, how many doses required

CompanyPriceDosage
ModernRs 1850 to 27502
PfizerRs.14502
SerumRs.500 to Rs.6002
Sputnik-5Price not stated2


No comments: